GRANDAR

GRANDAR contains Granisetron, a widely used antiemetic for the prevention and control of nausea and vomiting in different clinical settings. These symptoms are frequently seen in patients undergoing chemotherapy, radiotherapy, or surgical procedures, and can have a significant impact on their comfort and recovery.In day-to-day hospital practice, managing nausea and vomiting effectively is important—not just for patient comfort, but also to ensure that ongoing treatments can continue without interruption. GRANDAR helps meet this need by offering consistent and dependable symptom control. Its use allows patients to better tolerate therapy and supports a smoother recovery, particularly in the post-operative phase.

Mechanism of Action

Granisetron works by selectively blocking serotonin (5-HT3) receptors, which are involved in triggering nausea and vomiting. These receptors are present in the gastrointestinal tract as well as in the central nervous system.During chemotherapy, radiotherapy, or after surgery, serotonin is released and activates these receptors, leading to nausea and vomiting. By blocking this response, GRANDAR helps prevent these symptoms from occurring, providing effective and sustained relief.

Indications

GRANDAR is indicated for the prevention and management of:

• Chemotherapy-induced nausea and vomiting (CINV)
• Radiotherapy-induced nausea and vomiting
• Post-operative nausea and vomiting (PONV)

Key Benefits

• Provides reliable control of nausea and vomiting
• Improves patient comfort during cancer treatment
• Helps patients tolerate chemotherapy and radiotherapy more effectively
• Useful in managing post-operative discomfort
• Commonly used in hospital and clinical settings
• Supports uninterrupted treatment and recovery

Dosage and Administration

GRANDAR should be administered under the supervision of a qualified healthcare professional. It is usually given as an intravenous injection.The dose and timing depend on the type of treatment and the patient’s clinical condition. It is often administered prior to chemotherapy, radiotherapy, or surgery to help prevent the onset of symptoms. The exact dosage is determined by the treating physician based on individual requirements.

Why Choose GRANDAR?

GRANDAR provides a dependable option for the management of nausea and vomiting in clinical practice. With a well-established molecule and consistent performance, it helps deliver effective symptom control across different treatment settings.Its reliability makes it suitable for both preventive and supportive use, especially in patients undergoing intensive therapies. Manufactured under strict quality standards, GRANDAR offers confidence to healthcare professionals while helping improve patient comfort and overall treatment experience.